<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35838935</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>Brain structural and perfusion changes in amyotrophic lateral sclerosis-frontotemporal dementia patients with cognitive and motor onset: a preliminary study.</ArticleTitle><Pagination><StartPage>2164</StartPage><EndPage>2174</EndPage><MedlinePgn>2164-2174</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-022-00686-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) is rare but exhibits worse prognosis than either ALS or FTD alone. However, cognitive onset ALS-FTD (ALS-FTD-C) confers significantly better patient survival than does motor onset ALS-FTD (ALS-FTD-M), underscoring a meager understanding of pathological group differences. This study aimed to assess disparities in cortical atrophy and perfusion shown by patients with the above disease variants. A total of 38 participants (ALS-FTD-C, 8; ALS-FTD-M, 6; simultaneous-onset ALS-FTD [ALS-FTD-S], 4; healthy controls [HC], 20) qualified for the study and underwent magnetic resonance imaging scan. Three-dimensional T1-weighted structural brain imaging and 3D-pseudocontinuous arterial spin-labeled imaging were routinely collected. Gray matter volume (GMV) and cerebral blood flow (CBF) in ALS-FTD-C and ALS-FTD-M were compared through voxel-based analysis. Correlations between imaging parameters and clinical data were also assessed. Compared with HC, ALS-FTD had significant GMV reduction mainly in bilateral limbic system. GMV reduction in ALS-FTD-C was similar in pattern but less widespread, whereas ALS-FTD-M lacked any significant GMV reduction. In CBF analyses, ALS-FTD displayed hypoperfusion in bilateral motor cortex, frontotemporal lobe, and left basal ganglia. Hypoperfusion involved bilateral temporal lobe, prefrontal cortex, and putamen in ALS-FTD-C but was limited to left parahippocampal gyrus in ALS-FTD-M. Correlations between clinical data and GMV/CBF changes in specific regions were also identified in ALS-FTD. Group-specific patterns of cortical atrophy and perfusion were evident in ALS-FTD-C and ALS-FTD-M. ALS-FTD-C showed pronounced cortical atrophy and hypoperfusion, which were otherwise minimal in ALS-FTD-M. Above findings preliminarily revealed the pathological group differences that may help in classifying patients with ALS-FTD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yanying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shen</LastName><ForeName>Dongchao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xunzhe</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Liying</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5369-1541</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Chinese Academy of Medical Sciences, Beijing, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS-FTD</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">gray matter</Keyword><Keyword MajorTopicYN="N">perfusion</Keyword><Keyword MajorTopicYN="N">phenotypic variability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>12</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35838935</ArticleId><ArticleId IdType="doi">10.1007/s11682-022-00686-x</ArticleId><ArticleId IdType="pii">10.1007/s11682-022-00686-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agosta, F., Valsasina, P., Riva, N., Copetti, M., Messina, M. J., Prelle, A., ..., Filippi, M. (2012). The cortical signature of amyotrophic lateral sclerosis. PLoS One, 7(8), e42816. https://doi.org/10.1371/journal.pone.0042816 .</Citation></Reference><Reference><Citation>Ahmed, R. M., Devenney, E. M., Strikwerda-Brown, C., Hodges, J. R., Piguet, O., &amp; Kiernan, M. C. (2020). Phenotypic variability in ALS-FTD and effect on survival. Neurology, 94(19), e2005&#x2013;e2013. https://doi.org/10.1212/WNL.0000000000009398</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009398</ArticleId><ArticleId IdType="pubmed">32277059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner, J., &amp; Friston, K. J. (2000). Voxel-based morphometry--the methods. Neuroimage, 11(6 Pt 1), 805&#x2013;821. https://doi.org/10.1006/nimg.2000.0582 .</Citation></Reference><Reference><Citation>Bede, P., Omer, T., Finegan, E., Chipika, R. H., Iyer, P. M., Doherty, M. A., ..., Hardiman, O. (2018). Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging and Behavior, 12(6), 1696&#x2013;1707. https://doi.org/10.1007/s11682-018-9837-9 .</Citation></Reference><Reference><Citation>Buhour, M. S., Doidy, F., Laisney, M., Pitel, A. L., de La Sayette, V., Viader, F., ..., Desgranges, B. (2017a). Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET. Brain Imaging and Behavior, 11(1), 240&#x2013;252. https://doi.org/10.1007/s11682-016-9521-x .</Citation></Reference><Reference><Citation>Buhour, M. S., Doidy, F., Mondou, A., P&#xe9;lerin, A., Carluer, L., Eustache, F., ..., Desgranges, B. (2017b). Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis. EJNMMI Research, 7(1), 21. https://doi.org/10.1186/s13550-017-0267-2 .</Citation></Reference><Reference><Citation>Burrell, J. R., Kiernan, M. C., Vucic, S., &amp; Hodges, J. R. (2011). Motor Neuron dysfunction in frontotemporal dementia. Brain, 134, 2582&#x2013;2594. https://doi.org/10.1093/brain/awr195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr195</ArticleId><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell, J. R., Halliday, G. M., Kril, J. J., Ittner, L. M., G&#xf6;tz, J., Kiernan, M. C., &amp; Hodges, J. R. (2016). The frontotemporal dementia-motor neuron disease continuum. Lancet, 388(10047), 919&#x2013;931. https://doi.org/10.1016/s0140-6736(16)00737-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., &amp; Nakanishi, A. (1999). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences, 169(1&#x2013;2), 13&#x2013;21. https://doi.org/10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y., Kumfor, F., Landin-Romero, R., Irish, M., &amp; Piguet, O. (2019). The Cerebellum in Frontotemporal Dementia: a Meta-Analysis of Neuroimaging Studies. Neuropsychology Review, 29(4), 450&#x2013;464. https://doi.org/10.1007/s11065-019-09414-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-019-09414-7</ArticleId><ArticleId IdType="pubmed">31428914</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni, M., Contarino, V. E., Catricala, E., Dalla Bella, E., Pensato, V., Gellera, C., ..., Cappa, S. F. (2018). Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis. Neuroimage Clinical, 19, 675&#x2013;682. https://doi.org/10.1016/j.nicl.2018.05.020 .</Citation></Reference><Reference><Citation>Cui, B., Cui, L., Gao, J., Liu, M., Li, X., Liu, C., ..., Fang, J. (2015). Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis. PLoS One, 10(9), e0137921. https://doi.org/10.1371/journal.pone.0137921 .</Citation></Reference><Reference><Citation>DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., ..., Rademakers, R. (2011). Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron, 72(2), 245&#x2013;256. https://doi.org/10.1016/j.neuron.2011.09.011 .</Citation></Reference><Reference><Citation>Ferraro, P. M., Jester, C., Olm, C. A., Placek, K., Agosta, F., Elman, L., ..., McMillan, C. T. (2018). Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Neurobiology of Aging, 68, 85&#x2013;92. https://doi.org/10.1016/j.neurobiolaging.2018.04.008 .</Citation></Reference><Reference><Citation>Folstein, M. F., Folstein, S. E., &amp; McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189&#x2013;198. https://doi.org/10.1016/0022-3956(75)90026-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj, E., Le Ber, I., Lacomblez, L., Dubois, B., Verpillat, P., Didic, M., ..., Habert, M. O. (2007). Brain spect perfusion of frontotemporal dementia associated with motor neuron disease. Neurology, 69(5), 488&#x2013;490. https://doi.org/10.1212/01.wnl.0000266638.53185.e7</Citation></Reference><Reference><Citation>Hu, W. T., Seelaar, H., Josephs, K. A., Knopman, D. S., Boeve, B. F., Sorenson, E. J., ..., Grossman, M. (2009). Survival profiles of patients with frontotemporal dementia and motor neuron disease. Archives of Neurology, 66(11), 1359&#x2013;1364. https://doi.org/10.1001/archneurol.2009.253</Citation></Reference><Reference><Citation>Kansal, K., Mareddy, M., Sloane, K. L., Minc, A. A., Rabins, P. V., McGready, J. B., &amp; Onyike, C. U. (2016). Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis. Dementia and Geriatric Cognitive Disorders, 41(1&#x2013;2), 109&#x2013;122. https://doi.org/10.1159/000443205</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443205</ArticleId><ArticleId IdType="pubmed">26854827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth, C., Anderson, T., &amp; Miller, B. (2002). The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology, 59(7), 1077&#x2013;1079. https://doi.org/10.1212/wnl.59.7.1077</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.59.7.1077</ArticleId><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts, J., Loewe, K., Kaufmann, J., Jakubiczka, S., Abdulla, S., Petri, S., ..., Bede, P. (2015). Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology, 85(15), 1301&#x2013;1309. https://doi.org/10.1212/wnl.0000000000002017 .</Citation></Reference><Reference><Citation>Marin, B., Boum&#xe9;diene, F., Logroscino, G., Couratier, P., Babron, M. C., Leutenegger, A. L., ..., Beghi, E. (2017). Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. International Journal of Epidemiology, 46(1), 57&#x2013;74. https://doi.org/10.1093/ije/dyw061</Citation></Reference><Reference><Citation>Montuschi, A., Iazzolino, B., Calvo, A., Moglia, C., Lopiano, L., Restagno, G., ..., Chi&#xf2;, A. (2015). Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. Journal of Neurology, Neurosurgery, and Psychiatry, 86(2), 168&#x2013;173. https://doi.org/10.1136/jnnp-2013-307223</Citation></Reference><Reference><Citation>M&#xfc;ller-G&#xe4;rtner, H. W., Links, J. M., Prince, J. L., Bryan, R. N., McVeigh, E., Leal, J. P., ..., Frost, J. J. (1992). Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. Journal of Cerebral Blood Flow and Metabolism, 12(4), 571&#x2013;583. https://doi.org/10.1038/jcbfm.1992.81</Citation></Reference><Reference><Citation>Murphy, J., Factor-Litvak, P., Goetz, R., Lomen-Hoerth, C., Nagy, P. L., Hupf, J., ..., Mitsumoto, H. (2016). Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology, 86(9), 813&#x2013;820. https://doi.org/10.1212/wnl.0000000000002305</Citation></Reference><Reference><Citation>Nasreddine, Z. S., Phillips, N. A., B&#xe9;dirian, V., Charbonneau, S., Whitehead, V., Collin, I., ..., Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695&#x2013;699. https://doi.org/10.1111/j.1532-5415.2005.53221.x .</Citation></Reference><Reference><Citation>Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., ..., Lee, V. M. Y. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130&#x2013;133. https://doi.org/10.1126/science.1134108</Citation></Reference><Reference><Citation>Niccoli, T., Partridge, L., &amp; Isaacs, A. M. (2017). Ageing as a risk factor for ALS/FTD. Human Molecular Genetics, 26(R2), R105&#x2013;r113. https://doi.org/10.1093/hmg/ddx247</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx247</ArticleId><ArticleId IdType="pubmed">28977441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzarotti, B., Palesi, F., Vitali, P., Castellazzi, G., Anzalone, N., Alvisi, E., ..., Gandini Wheeler-Kingshott, C. A. M. (2020). Frontal and Cerebellar Atrophy Supports FTSD-ALS Clinical Continuum. Frontiers in Aging Neuroscience, 12, 593526. https://doi.org/10.3389/fnagi.2020.593526</Citation></Reference><Reference><Citation>Prell, T., &amp; Grosskreutz, J. (2013). The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 14(7&#x2013;8), 507&#x2013;515. https://doi.org/10.3109/21678421.2013.812661</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812661</ArticleId><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan, V., &amp; Pioro, E. P. (2014). Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study. Amyotroph Lateral Scler Frontotemporal Degener, 15(3&#x2013;4), 216&#x2013;225. https://doi.org/10.3109/21678421.2014.880179</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.880179</ArticleId><ArticleId IdType="pubmed">24555884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan, V., &amp; Pioro, E. P. (2015). Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question. Journal of Neurology, Neurosurgery, and Psychiatry, 86(9), 952&#x2013;958. https://doi.org/10.1136/jnnp-2014-308239</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308239</ArticleId><ArticleId IdType="pubmed">25520437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan, V., &amp; Pioro, E. P. (2020). 2-Deoxy-2-[(18) F]fluoro-d-glucose positron emission tomography, cortical thickness and white matter graph network abnormalities in brains of patients with amyotrophic lateral sclerosis and frontotemporal dementia suggest early neuronopathy rather than axonopathy. European Journal of Neurology. https://doi.org/10.1111/ene.14332</Citation></Reference><Reference><Citation>Ramasubbu, R., Brown, E. C., Marcil, L. D., Talai, A. S., &amp; Forkert, N. D. (2019). Automatic classification of major depression disorder using arterial spin labeling MRI perfusion measurements. Psychiatry and Clinical Neurosciences, 73(8), 486&#x2013;493. https://doi.org/10.1111/pcn.12862</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12862</ArticleId><ArticleId IdType="pubmed">31077500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti, E., Domoto-Reilly, K., Caso, C., Murphy, A., Brickhouse, M., Hochberg, D., ..., Dickerson, B. C. (2021). Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD. Brain Imaging and Behavior, 15(5), 2540&#x2013;2551. https://doi.org/10.1007/s11682-021-00456-1</Citation></Reference><Reference><Citation>Renard, D., Collombier, L., Castelnovo, G., Fourcade, G., Kotzki, P. O., &amp; LaBauge, P. (2011). Brain FDG-PET changes in ALS and ALS-FTD. Acta Neurologica Belgica, 111(4), 306&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">22368970</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A. E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J. R., ..., Consortium, I. (2011). A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron, 72(2), 257&#x2013;268. https://doi.org/10.1016/j.neuron.2011.09.010</Citation></Reference><Reference><Citation>Ringholz, G. M., Appel, S. H., Bradshaw, M., Cooke, N. A., Mosnik, D. M., &amp; Schulz, P. E. (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology, 65(4), 586&#x2013;590. https://doi.org/10.1212/01.wnl.0000172911.39167.b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000172911.39167.b6</ArticleId><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelley, B. P., &amp; Trimble, M. R. (2004). The insular lobe of Reil--its anatamico-functional, behavioural and neuropsychiatric attributes in humans--a review. The World Journal of Biological Psychiatry, 5(4), 176&#x2013;200. https://doi.org/10.1080/15622970410029933 .</Citation></Reference><Reference><Citation>Shen, D., Hou, B., Xu, Y., Cui, B., Peng, P., Li, X., ..., Cui, L. (2018). Brain Structural and Perfusion Signature of Amyotrophic Latera Sclerosis With Varying Levels of Cognitive Deficit. Frontiers in Neurology, 9. https://doi.org/10.3389/fneur.2018.00364</Citation></Reference><Reference><Citation>Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., McLaughlin, P., Snowden, J., ..., Turner, M. R. (2017). Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(3&#x2013;4), 153&#x2013;174. https://doi.org/10.1080/21678421.2016.1267768</Citation></Reference><Reference><Citation>Tan, R. H., Devenney, E., Dobson-Stone, C., Kwok, J. B., Hodges, J. R., Kiernan, M. C., ..., Hornberger, M. (2014). Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One, 9(8), e105632. https://doi.org/10.1371/journal.pone.0105632</Citation></Reference><Reference><Citation>Tan, J. P., Li, N., Gao, J., Wang, L. N., Zhao, Y. M., Yu, B. C., ..., Zhou, P. Y. (2015). Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population. Journal of Alzheimer's Disease, 43(4), 1403&#x2013;1412. https://doi.org/10.3233/jad-141278</Citation></Reference><Reference><Citation>Verfaillie, S. C., Adriaanse, S. M., Binnewijzend, M. A., Benedictus, M. R., Ossenkoppele, R., Wattjes, M. P., ..., Barkhof, F. (2015). Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? European Radiology, 25(10), 3050&#x2013;3059. https://doi.org/10.1007/s00330-015-3696-1</Citation></Reference><Reference><Citation>Wang, H., Li, S., Chen, X., Wang, Y., Li, J., &amp; Wang, Z. (2020). Cerebral Blood Flow Alterations in High Myopia: An Arterial Spin Labeling Study. Neural Plasticity, 2020, 6090262. https://doi.org/10.1155/2020/6090262</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6090262</ArticleId><ArticleId IdType="pubmed">32399025</ArticleId><ArticleId IdType="pmc">7199639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>